Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
暂无分享,去创建一个
J. Reeves | P. Hegde | A. Ravaud | J. Hainsworth | R. Motzer | M. Gore | T. Powles | W. Rathmell | T. Choueiri | M. Atkins | M. Sznol | B. Rini | S. Jhunjhunwala | W. Stadler | B. Escudier | L. Fong | S. Pal | D. Nickles | Daniel S Chen | G. Fine | R. Joseph | Mahrukh A. Huseni | S. Bracarda | D. McDermott | C. Suarez | Thomas E. Hutson | R. Danielli | V. Gruenwald | E. Piault-Louis | A. Thobhani | J. Qiu | C. Schiff | Daniel S. Chen | T. Hutson | M. Huseni